Cutaneous Squamous Cell Carcinoma (cscc) Clinical Trials
2 recruiting trials for Cutaneous Squamous Cell Carcinoma (cscc). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cutaneous Squamous Cell Carcinoma (cscc) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 3 is the largest group at 50% (1 studies); the largest phase groups are Phase 3: 1, Phase 1: 1.
Research is led by Regeneron Pharmaceuticals (1), KaliVir Immunotherapeutics (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cemiplimab (drug, 1 trial), followed by Standard of care, VET3-TGI.
Track Cutaneous Squamous Cell Carcinoma (cscc) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
This study will test a study drug called cemiplimab to see if it can help treat early-stage Cutaneous Squamous Cell Carcinoma (CSCC), a type of skin cancer. Cemiplimab works by...
A Study of VET3-TGI in Patients With Solid Tumors
VET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study is designed to find a safe and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cutaneous Squamous Cell Carcinoma (cscc), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cutaneous Squamous Cell Carcinoma (cscc), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Cutaneous Squamous Cell Carcinoma (cscc), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.